many articles surfacing on tamiflu resistance, page-19

There are many views in the market, most conservative and looking at the recent share price performance why shouldn't it be.

Personally I think the market will start to wake up to BTA's potential over the coming months. Have a look back through announcements from the settlement... all very positive.

Management have done a great job developing the pipeline. For a biotech company that is what you want... they have even secured some handsome arrangements for example RSV. HRV and LANI are hopefully next.

There is just no way I'm selling a single share at these prices... I'm holding till we see deals for LANI and HRV and probably then some. My target is optimistic, but as a biotech investor sometimes you have to be :)

Good luck all.